Oxford University Press, The Journal of Infectious Diseases, 4(205), p. 557-567, 2012
Full text: Download
Background. The dynamics of raltegravir-resistant variants and their impact on virologic response in 23 HIV-1–infected patients, who started a salvage raltegravir-containing regimen, were investigated.